Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ).
Dawnrays Pharmaceutical Holdings Ltd. has announced a board meeting scheduled for March 28, 2025, to approve the annual results for the year ending December 31, 2024, and consider the recommendation of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
YTD Price Performance: -0.82%
Average Trading Volume: 167,686
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$1.82B
Find detailed analytics on 2348 stock on TipRanks’ Stock Analysis page.